COVID-19 Pandemic - The government presents its daily update
QUÉBEC CITY, Oct. 13, 2021 /CNW Telbec/ - The most recent data on the evolution of COVID-19, in the last 24 hours, in Québec show:
512 new cases, bringing the total number of people infected to 417,188;
400,777 people have recovered;
7 new deaths, for a total of 11,429 deaths;
298 hospitalizations, for an increase of 7 compared to the previous day;
21 new entries
14 new discharges
75 people in intensive care, for an increase of 3 compared to the previous day;
7 new entries
4 new discharges
26,148 samples conducted on October 11.
Vaccination
9,806 doses administered are added, that is 9,336 doses in the last 24 hours and 470 doses before October 12, for a total of 13,043,540 doses administered in Québec. Outside Québec, a total of 202,369 doses were administered, for a cumulative total of 13,245,909 doses received by Quebecers.
To follow the evolution of the data on a daily basis, consult the open data or the INSPQ website at https://www.donneesquebec.ca/recherche/fr/organization/msss or at https://www.inspq.qc.ca/covid-19/donnees. Note that the number of cases, deaths and doses administered, in particular, may be subject to daily readjustment for previous days, given that a catch-up is necessary due to a delay in data entry.
A reminder concerning public health instructions:
To limit the spread of the coronavirus as much as possible, it is important to follow basic preventive measures such as hand washing, physical distancing, wearing a face covering and following the instructions in effect in your region.
Remember that in the event of symptoms, it is always essential to isolate yourself and consult one of the self-care guides or call 1-877-644-4545 (or the telephone code corresponding to the region concerned) to find out the measures to be taken.
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in thedevelopment oftherapeutics for age-related diseases, today annouces that it will change the ratio...
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...